Correlation Between Green Thumb and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Green Thumb and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green Thumb and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Green Thumb Industries and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Green Thumb and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green Thumb with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green Thumb and Takeda Pharmaceutical.
Diversification Opportunities for Green Thumb and Takeda Pharmaceutical
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Green and Takeda is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Green Thumb Industries and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Green Thumb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green Thumb Industries are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Green Thumb i.e., Green Thumb and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between Green Thumb and Takeda Pharmaceutical
Assuming the 90 days horizon Green Thumb Industries is expected to under-perform the Takeda Pharmaceutical. But the otc stock apears to be less risky and, when comparing its historical volatility, Green Thumb Industries is 1.19 times less risky than Takeda Pharmaceutical. The otc stock trades about -0.1 of its potential returns per unit of risk. The Takeda Pharmaceutical Co is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 2,665 in Takeda Pharmaceutical Co on October 6, 2024 and sell it today you would earn a total of 10.00 from holding Takeda Pharmaceutical Co or generate 0.38% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Green Thumb Industries vs. Takeda Pharmaceutical Co
Performance |
Timeline |
Green Thumb Industries |
Takeda Pharmaceutical |
Green Thumb and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Green Thumb and Takeda Pharmaceutical
The main advantage of trading using opposite Green Thumb and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green Thumb position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.Green Thumb vs. Curaleaf Holdings | Green Thumb vs. Trulieve Cannabis Corp | Green Thumb vs. Cresco Labs | Green Thumb vs. GrowGeneration Corp |
Takeda Pharmaceutical vs. Astellas Pharma | Takeda Pharmaceutical vs. Daiichi Sankyo | Takeda Pharmaceutical vs. Chugai Pharmaceutical Co | Takeda Pharmaceutical vs. Bayer AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |